Fig. 3From: Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistancePrognosis analysis for the EIC and the rest class across different stages of LUSC. A–C Kaplan–Meier estimates of overall survival for the EIC and the rest class across late-stage, early-stage, and all-stage LUSC. Survival data was limited to maximum 5 years (60 months). D–F Kaplan–Meier estimates of progression-free survival for the EIC and the rest class across late-stage, early-stage, and all-stage LUSC. P-values were calculated by log-rank test. Survival data was limited to maximum 5 years (60 months). G,H Multivariate Cox regression analysis on four variables (class, gender, tumour stage, and age) for late-stage and all-stage LUSCBack to article page